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Abstract 
Transmetallation reactions of ortho-mercurated iminophosphoranes (2-
ClHgC6H4)Ph2P=NR with [AuCl4]
-
 gives new cycloaurated iminophosphorane 
complexes of gold(III) (2-Cl2AuC6H4)Ph2P=NR [R = (R,S)- or (S)-CHMePh, p-C6H4F, 
t
Bu], characterised by NMR and IR spectroscopies, ESI mass spectrometry and an X-
ray structure determination on the chiral derivative R = (S)-CHMePh. The chloride 
ligands of these complexes can be readily replaced by the chelating ligands 
thiosalicylate and catecholate; the resulting derivatives show markedly higher 
 2 
antitumour activity versus P388 murine leukemia cells compared to the parent 
chloride complexes. Reaction of (2-Cl2AuC6H4)Ph2P=NPh with PPh3 results in 
displacement of a chloride ligand giving the cationic complex [(2-
Cl(PPh3)AuC6H4)Ph2P=NPh]
+
, indicating that the P=N donor is strongly bonded to 
the gold centre. 
 
Keywords: Gold complexes; Iminophosphorane complexes; Ligand substitution; X-
ray crystal structures 
 
Introduction 
 Gold complexes are well-known to show interesting biological
1-3
 and 
catalytic
4-5
 behaviour. Complexes containing cycloaurated ligands are of interest for 
the stabilisation of the gold(III) centre that they impart. However, the number of 
ligands that form cycloaurated gold(III) complexes with C,N donor atoms are 
relatively few compared with other platinum group metals. The syntheses and 
reactivity of such Au(III) complexes is the subject of a recent review.
6
 
 Iminophosphoranes (of the general formula R3P=NR’) are attractive 
candidates as ligands not only because the phosphorus atom introduces a powerful 
(
31
P NMR) spectroscopic probe, but also due to their facile synthesis. Using either the 
Staudinger reaction between an organic azide and a tertiary phosphine (R3P + N3R’ 
→ R3P=NR’), or the Kirsanov reaction between a phosphine dibromide and a primary 
amine (R3PBr2 + H2NR’ → R3P=NR’), the organic moieties of the iminophosphorane 
can easily be modified to give ligands with different steric and electronic properties.
7
 
 3 
 Transition metal iminophosphorane complexes are well known in the 
literature. Bielsa et al. have recently published a paper which thoroughly summarises 
the different coordination modes of iminophosphorane ligands, commenting however 
that examples of ortho-metallated complexes are scarce.
8
  The first ortho-metallated 
complexes, formed directly by the reaction of the iminophosphorane ligands 
(Ar3P=NR; Ar = Ph, p-CH3C6H5; R = m-CH3C6H5, p-CH3C6H5, p-CH3OC6H5) with 
Na2PdCl4, were reported by Alper in 1977.
9
 Later, examples of the ortho-manganated 
and –rheniated iminophosphorane Ph3P=NPh were reported,
10
 and ortho-metallated 
palladium(II),
8,11-13 
iridium, rhodium
14
 and main group complexes
15
 are also known. 
Recently, we have reported the synthesis of cycloaurated Ph3P=NPh 1 from the 
ortho-mercurated compound 2.
16
 Following this, a report on a ‘greener’ synthetic 
route to 1 from the corresponding gold(I) complex 3 was published along with 
evidence that 1 and related compounds are effective at catalysing the addition of 
electron rich arenes and 2-methylfuran to methyl vinyl ketone.
17
 In addition there are 
a number of ortho-metallated derivatives of related silyl-iminophosphoranes.
15,18-20
 
This paper gives new examples of both cycloaurated and ortho-mercurated N-alkyl 
and –aryl iminophosphoranes; the reactivity and a preliminary assessment of the 
biological activity of these compounds is also reported. 
 
Results and discussion 
 Scheme 1 summarises the syntheses of both ortho-mercurated and 
cycloaurated iminophosphoranes. The Kirsanov reaction between primary 
alkylamines and Ph3PBr2 yields the alkylaminophosphonium salts [R3P-NH-R’]Br 
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almost quantitatively. Subsequent deprotonation of these salts by addition of a base 
yields the neutral iminophosphorane ligands. The use of arylamines in the synthesis 
gives the iminophosphorane ligands directly.
7
 Lee and Singer have reported that the 
deprotonation of aminophosphonium salts takes place readily and in high yields using 
KOH as the base.
21
 However, our experience showed that yields were often lower 
than reported and the resulting iminophosphoranes were unstable towards hydrolysis, 
especially when the N-bonded substituent was -CHMePh. 
 Boubekeur et al. have recently shown that isolation of the 
iminophosphorane is not necessary - reaction of alkylaminophosphonium salts with 
two equivalents of n-butyllithium leads to deprotonatation of the phosphonium salt 
and ortho-lithiation of the resulting iminophosphorane in one step.
22
 We have adapted 
this methodology to synthesize ortho-mercurated iminophosphoranes in a one-pot 
reaction. Thus, when the alkylaminophosphonium salts were reacted with two 
equivalents of n-butyllithium followed by HgCl2, the ortho-mercurated bromide 
compounds were isolated in good yields. In contrast, the aryliminophosphorane 
ligands are appreciably more stable. They can be isolated in good yields and reacted 
with PhLi followed by HgCl2, as previously described,
16,17
 to give the ortho-
mercurated compounds, also in good yields. 
 Vicente et al.
23
 have demonstrated that direct mercuration of 
Ph3P=NC6H4Me gives the ortho-mercurated compound with the mercury bound to 
the p-tolyl ring, the wrong isomer for subsequent cycloauration. The use of 
Ph3P=NBu
t
 eliminates the possibility of metallation on the N-substituent and when 
reacted directly with Hg(OAc)2 in THF it appears that mercuration takes place in the 
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desired position – on the ortho position of a P-bonded phenyl ring. However, yields 
were low compared with the synthetic route that proceeds via the ortho-lithiated 
intermediate, and appreciable decomposition of the ligand to [Ph3P-NH-Bu
t
]
+
 and 
Ph3P=O is observed by 
31
P{
1
H} NMR during the reaction.   
 Transmetallation of either the ortho-mercurated chloride or bromide species 
with NMe4[AuCl4] produced the cycloaurated complexes in good yields. In all cases 
the gold(III) dichloride is formed and no evidence of mono- or di-brominated 
compounds are seen, even when the bromo-mercury iminophosphoranes are used.  
 Using the above methodology, the ortho-mercurated compounds 9-12 and 
the cycloaurated complexes 13-16 were successfully synthesised. With the exception 
of 14 which decomposed slowly over time, all the compounds (including the racemic 
mixture 13) appear to be stable towards air and light. The compounds were analysed 
by mass spectrometry, IR and NMR spectroscopy and microelemental analysis. In 
addition, an X-ray structure determination of the chiral complex 14 was carried out. 
 
X-ray crystal structure of (2-Cl2AuC6H4)Ph2P=N-(S)-CHMePh 14 
 In order to fully characterise (2-Cl2AuC6H4)Ph2P=N-(S)-CHMePh 14 and 
compare it with the N-aryl complex 1, an X-ray crystal structure determination was 
carried out. Figure 1 shows the structure of the complex with the atom labelling 
scheme, while Table 1 gives important bond parameters. The crystal is a rare example 
of a P1, Z = 1 structure. The gold atom is essentially square planar with C(12) 
showing the greatest deviation from the coordination plane [defined by C(12), N(1), 
Au(1), Cl(1) and Cl(2)]. Because of the greater trans influence of the aryl carbon, the 
 6 
Au-Cl(1) bond length is greater than the Au-Cl(2) bond length trans to the nitrogen. 
The metallacyclic ring made up of Au(1), N(1), P(1), C(11) and C(12) is significantly 
puckered, as in the previously characterised cycloaurated iminophosphorane 1.
16
 
Again, the nitrogen atom shows the greatest deviation [0.288(5) Å above the plane]. 
The bond lengths and angles in 14 are generally similar to those in the N-phenyl 
complex 1.
16 
However, compared to 1, the Au(1)-N(1) bond of 14 is longer 
[2.072(10) versus 2.034(4) Å] and the trans chloride Au(1)-Cl(2) of 14 is slightly 
shorter [2.297(3) versus 2.289(1) Å]. This indicates that the N(alkyl) group has a 
slightly lower trans influence than the NPh group, which may have implications in 
the catalytic activity of such complexes.
17
 
 
 
Spectroscopic and mass spectrometric characterisation 
 Because of the presence of multiple inequivalent phenyl rings and coupling 
to phosphorus in the ortho-mercurated and cycloaurated complexes, both the 
1
H and 
13
C{
1
H} NMR spectra are complex and difficult to fully interpret. 
31
P{
1
H} NMR 
remains the most useful experiment. The ortho-mercurated complexes have chemical 
shifts ranging from 2.2 ppm (12) to 14.8 ppm (9/10), with 
3
J(
199
Hg-P) coupling 
averaging 330 Hz. Upon transmetallation to the cycloaurated complexes, there is a 
significant downfield shift in the signal of approximately 50 ppm, consistent with the 
formation and inclusion of the phosphorus in a 5-membered ring.
24
 
 The ESI-MS of the ortho-mercurated complexes 9-12 all show strong 
[M+H]
+
 ions which can easily be identified by the characteristic isotope pattern of 
 7 
mercury. Complex 12 also indicated the presence of the diarylmercury complex 2-
Hg({C6H4}Ph2P=N
t
Bu)2 however there was no evidence of this compound in the 
31
P{
1
H} NMR spectrum or microelemental analysis. This form of ionisation is 
consistent with little N-Hg interaction in these species, leaving the N available for 
protonation.  
 In contrast, the primary route of ionisation for the cycloaurated complexes 
appears to be loss of a chloride ligand to give the ions [M-Cl]
+
, protonation to give 
[M+H]
+
 being precluded by the strong N-Au bond. As previously observed, addition 
of a small amount of highly coordinating pyridine produces the species [M-Cl+py]
+
.
25
 
Interestingly, the complex 16 also shows the ion [M+Me4N]
+
 with traces of the cation 
carried over from Me4N[AuCl4] and Me4NCl in the synthesis. The Me4N
+
 cation 
would be expected to have very high ionisation efficiency in ESI MS when compared 
to a neutral gold complex; no evidence of Me4N
+
 is observed in NMR spectra. This 
type of adduct is the predominant gold species when monitoring the progression of 
the transmetallation reaction by ESI-MS. 
 
Reactivity of cycloaurated iminophosphorane complexes with dianionic ligands 
 The chloride ligands on C,N cyclometallated Au(III) compounds can be 
readily replaced by dianionic ligands such as catecholate
26
 and thiosalicylate,
27-29
 
forming new five- and six-membered chelate rings respectively. Such complexes are 
of interest because other analogues containing these anionic ligands have shown good 
anti-tumour activity. The iminophosphorane complexes 1 and 16 show analogous 
behaviour and when reacted with either catechol or thiosalicylic acid in methanol 
 8 
with excess trimethylamine, the cycloaurated complexes 17-20 can easily be isolated 
in high yields by addition of water to the reaction mixture. NMR spectroscopy, ESI 
mass spectrometry and microanalysis confirm the formulation. Compound 18 appears 
to crystallise with one molecule of water as microanalysis of two independent 
samples gave a composition which is in agreement with the proposed formula. 
 The 
31
P{
1
H} NMR spectra of the new cycloaurated derivatives show only a 
slight difference in chemical shift from the original dichloride species. The chemical 
shift of 1 is 65.5 ppm
16
 whereas 17 and 19 have shifts of 60.9 and 54.1 ppm 
respectively. Likewise, the dichloride 16 has a shift of 46.1 ppm, which moves 
slightly to 55.7 and 43.2 ppm in 18 and 20 respectively. Such data indicate that the 
original cycloaurated iminophosphorane ring remains intact upon derivatisation; if the 
ring was opened an upfield shift in the 
31
P{
1
H} spectrum would be expected.
24
 
 Both the catechol and thiosalicylate derivatives show clean mass spectra 
and, with the exception of 19, have strong parent ions of the type [M+H]
+
 or [M+Na]
+
 
when the sample is doped with NaCl. However for the complex 19, the parent ion is 
[2-Au({C6H4}Ph2P=NPh)2]
+
, even when the sample is doped with NaCl. The 
presence of this type of diarylgold species in ESI-MS spectra of thiosalicylate 
complexes has been seen previously.
29 
 To confirm the geometry of the thiosalicylate complexes, an X-ray crystal 
structure of 20 was carried out. Figure 2 shows the molecular structure with the atom 
labelling scheme, and Table 2 gives selected bond lengths and angles. As with other 
gold(III) thiosalicylate complexes
27-29
 the ligand is coordinated to the gold with the 
two highest trans influence donors (aryl C and thiolate S) mutually cis to each other. 
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The geometry around the gold is square planar with the largest deviation from the 
N(1), C(12), Au(1), S(1) and O(2) plane being for C(12), which sits 0.1620(7) Å 
below the plane. The fold angle between the Au coordination plane [defined by 
Au(1), S(1) and O(2)] and the plane of the thiosalicylate ligand (excluding the oxygen 
atoms) is 43.34(4)°, which falls in the range of 30.1(8)° (21) and 59.6° (22) 
previously seen in gold(III) thiosalicylate systems.
27-29
 The bite angle of the 
thiosalicylate ligand is 91.46(4)°, comparable to those seen in (22) and (23) 
[89.82(8)° and 90.1(2)° respectively]. The five-membered ring created by the 
cycloaurated iminophosphorane is also puckered with the greatest deviations for N(1) 
(0.3226(7) Å above the plane) and P(1) (0.2788(7) Å below the plane).  The 
puckering of the thiosalicylate and the iminophosphorane rings can clearly be seen in 
Figure 3. The fold angle between the Au coordination plane and that of the 
thiosalicylate ring is 43.3˚, towards the lower end of the range found for a series of 
Pt(II) thiosalicylate complexes.
30
 
 
Reactivity with phosphines 
 Previously, reaction of C,N cyclometallated Au(III) dichloride complexes 
with PPh3 has given an indication of the strength of the N-Au bond.
6
 If the bond is 
strong, then a chloride ion will be displaced to give a cationic complex.  
Alternatively, if the N-Au bond is relatively weak, it will be cleaved and coordination 
of the phosphine will give a neutral phosphine complex. The behaviour is dependent 
on the ligand. For example, when the damp complex (Scheme 2a) is reacted with one 
equivalent of PPh3 substitution of the chloride takes place.
31
 In contrast, when 
 10 
papAuCl2 (Scheme 2b) is reacted in the same manner the nitrogen is displaced and 
the neutral phosphine complex is obtained.
 32,33
 
 To assess the strength of the Au-N bond in Au(III) iminophosphoranes, 1 
was reacted with one molar equivalent of PPh3 together with NH4PF6 in 
dichloromethane, producing the compound 24 where the PPh3 has displaced the 
chloride ligand. The products were initially characterised by ESI-MS and 
31
P{
1
H} 
NMR. The 
31
P{
1
H} NMR shows the expected two signals at 60.6 and 41.0 ppm in a 
1:1 ratio. The first arises from the iminophosphorane, and is only slightly shifted 
from that of the parent dichloride (65.5 ppm) indicating that the phosphorus is still 
present in a ring. This was unambiguously confirmed by an X-ray crystal structure 
determination. 
 The molecular structure of the cation of 24 is shown in Figure 4, and 
important bond parameters are presented in Table 3. The geometry around the gold 
atom is essentially square planar and N(1) shows the greatest deviation [0.113(3) Å] 
from the coordination plane. The X-ray crystal structure shows that the phosphine is 
coordinated trans to the nitrogen, thus placing the two softest ligands (the phosphine 
and aryl groups) mutually cis to each other, giving the most thermodynamically 
stable configuration (antisymbiosis).
34
 This is also observed in other phosphine 
substituted Au(III) cationic complexes, and the Au-P bond lengths are comparable 
with those previously seen.
35-38
 Upon substitution of the chloride with the bulky 
phosphine group the bond angle between the two monodentate ligands has increased 
[from 90.70(4)° in 1 to 92.88(17)° in 24] which in turn has decreased the bite angle of 
the iminophosphorane ligand [from 84.86(17) to 84.0(2)°]. However, the ligand 
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remains significantly puckered, with N(1) and P(1) showing the greatest deviation 
from the mean plane of the ring [defined by N(1), P(1), Au(1), C(11) and C(12)]. 
 
Attempted displacement of the N-donor ligand 
 In order to evaluate our hypothesis that displacement of the N-donor would 
result in a significant upfield shift in the 
31
P spectra from a monodentate 
iminophosphorane ligand we attempted to synthesise complexes of this type.  
Previously this has been achieved with gold(III) complexes by replacement of the 
relatively weakly bound chloride ligands with stronger cyanide
39
 or 
dithiocarbamate
40,41
 groups. 
 Cyanide complexes of the damp system have been spectroscopically 
characterised. Reaction of dampAuCl2 (see scheme 2) with two equivalents of KCN 
gave the neutral complex dampAu(CN)2, whereas excess cyanide gave the anionic 
[Au(damp)(CN)3]
-
 complex as the potassium salt.
28
 When 1 was reacted with excess 
KCN the corresponding anion could be seen in the ESI mass spectrum, and an 
unexpected new peak at 69.5 ppm in the 
31
P{
1
H} is observed. However, isolation and 
microanalysis of this complex as a white solid produced microelemental data 
completely inconsistent with the expected formulation. 
 Reaction of dampAuCl2 with one equivalent of NaS2CNMe2 produced the 
cationic complex 25. However, if two equivalents of dithiocarbamate were used a 
neutral complex was obtained where one dithiocarbamate ligand was coordinated in a 
bidentate fashion, the other as a monodentate ligand, as shown by an X-ray crystal 
 12 
structure analysis, 26. Rapid interchange between the ligands occurs on the NMR 
timescale.
39
 Analogous results are seen with oxazoline gold(III) complexes.
40
 
 When 1 is reacted with a molar equivalent of NaS2CNEt2 and NH4PF6 in 
dichloromethane the complex 27 is obtained as a yellow solid. The analogous 
reaction with two equivalents of NaS2CNEt2 also gives a yellow complex which is 
identical to 27 (on the basis of 
1
H and 
13
P{
1
H} NMR experiments). No evidence of 
the complex analogous to 26 is observed. These observations indicate that the 
iminophosphorane complexes contain a robust cyclometallated ring. 
 
 
Biological activity  
 A number of gold(III) complexes have previously been found to show 
anti-tumour activity.
6,41,42
 The biological activity of 1 has been reported, and showed 
low anti-cancer activity against the P388 murine leukemia cell line.
16
 In order to 
determine if this is characteristic of cycloaurated iminophosphoranes, the activity of 
the alkyl compound 16 was evaluated. The bicyclic catecholate (17 and 18) and 
thiosalicylate (19 and 20) derivatives were also evaluated, since related derivatives 
have been previously been found to exhibit high anti-tumour activity.
29
  
 Results of the biological assays are presented in Table 4. In contrast to the 
dichloride complexes 1 and 16 which show low anti-tumour activity, the catecholate 
and thiosalicylate complexes show a ten-fold increase in the level of activity. In 
particular the complexes 17 and 19, originating from complex 1, show a high level of 
activity. These observations confirm that the presence of catecholate or thiosalicylate 
 13 
ligands tends to lead to complexes with good activity, and warrants further detailed 
studies on these systems. 
 
Conclusions 
 A range of new ortho-mercurated and cycloaurated iminophosphorane 
complexes and their derivatives have been synthesised and fully characterised by 
NMR spectroscopy and ESI mass spectrometry. X-ray crystal structures of three of 
these compounds have been carried out. The Au–N coordinate bond is relatively 
strong because when 1 is reacted with PPh3 the Au–N bond remains intact and a 
chloride ligand is substituted by PPh3. Attempts at cleaving this bond by reacting 1 
with ligands such as CN
-
 and dithiocarbamates were unsuccessful. Both chloride 
ligands can be replaced by chelating dianionic ligands to give bi-metallacyclic 
compounds with enhanced anti-tumour activity, possibly due to the reduced reactivity 
of the complexes. 
 
Experimental 
 
General procedures 
 The known aminophosphonium salts 4 and 5 and the iminophosphoranes 7 
and 8 were prepared by literature procedures; 6 was prepared by a completely 
analogous method to 5.
7,21
 Complex 1 was prepared by the literature procedure.
16
 n-
Butyllithium (either 1.6 M in hexanes or 2.0 M in cyclohexane, Aldrich), PhBr 
(AJAX Chemicals), HgCl2, catechol, sodium diethyldithiocarbamate trihydrate 
 14 
(BDH), Hg(OAc)2 (Riedel de Haën) and thiosalicylic acid (Sigma) were used as 
received. Me4N[AuCl4] was prepared by reaction of HAuCl4.4H2O with Me4NCl. 
Dry de-oxygenated diethyl ether and THF were obtained from a Pure Solv™ solvent 
purification system, and metallation reactions were carried out under a nitrogen 
atmosphere using standard Schlenk techniques, with light also being excluded in the 
case of cycloauration reactions.   
 Positive ion ESI mass spectra were acquired on a VG Platform II 
instrument using methanol as the solvent after the compound had first been dissolved 
in a small amount of dichloromethane. IR spectra were acquired as KBr disks on a 
Digilab Scimitar FT-IR spectrometer. 
31
P{
1
H} and 
1
H NMR spectra (solvent CDCl3) 
were recorded on a Bruker DRX 300 FT NMR spectrometer at 121.5 and 300.1 MHz 
respectively. Microelemental analysis was carried out at the Campbell 
Microanalytical Laboratory at the University of Otago. Anti-tumour assays were 
carried out using previously described methods;
43 
samples were tested in a 2:1 
dichloromethane:methanol solvent system. 
 
Preparation of (2-BrHgC6H4)Ph2P=N-(R,S)-CHMePh 9   
[Ph3P-NH-(R,S)-CHMePh]
+
Br
-
 5 (1.000 g, 2.16 mmol) was suspended in diethyl ether 
(30 mL) and cooled to -84 ˚C in an ethyl acetate slush bath. nBuLi (1.6 M, 2.7 mL, 
4.32 mmol) was added dropwise with stirring. The solution was allowed to warm to 
room temperature to give a clear orange solution that was stirred for an additional 30 
min. HgCl2 (0.586 g, 2.16 mmol) was added in one portion and after stirring for 1 h 
the solvent was removed and the solid extracted into dichloromethane (2 × 10 mL), 
 15 
filtered and diethyl ether (20 mL) was added to the filtrate. Storage at -20 °C gave 
white crystals of (2-BrHgC6H4)Ph2P=N-(R,S)-CHMePh (0.606 g, 42%). Found: C 
47.7, H 3.6, N 2.2; C26H23NPBrHg requires C 47.3, H 3.5, N 2.1%. NMR: 
1
H:  δ 
(ppm) 1.64 (d, CH3), 4.68 (m, CH), 7.00-7.69 (m, Ar-H); 
31
P{
1
H}: δ (ppm) 14.8, 
3
J(
199
Hg-P) = 317 Hz. ESI-MS: m/z:  662 (100%, [M+H]
+
). IR:  υ(P=N) = 1163 cm-1 
(vs). 
 
Preparation of (2-BrHgC6H4)Ph2P=N-(S)-CHMePh 10  
As for the preparation of 9 above, [Ph3P-NH-(S)-CHMePh]
+
Br
-
 6 (2.000 g, 4.34 
mmol) was suspended in diethyl ether (30 mL) and 
n
BuLi (1.6 M, 5.4 mL, 8.68 
mmol) added. After addition of HgCl2 (1.178 g, 4.34 mmol), work-up as above gave 
1.780 g, (62%) of (2-BrHgC6H4)Ph2P=N-(S)-CHMePh. The product was identified by 
1
H and 
31
P{
1
H} NMR spectroscopy. 
 
Preparation of (2-ClHgC6H4)Ph2P=NC6H4F 11   
A solution of 
n
BuLi (2 mL, 2.69 mmol) was added to a solution of PhBr (0.28 mL, 
2.69 mmol) in diethyl ether (20 mL) and stirred for 15 min. Ph3P=NC6H4F 7 (1.000 g, 
2.69 mmol) was added to immediately give a dark orange solution. After stirring for 
1.5 h a white precipitate had formed. HgCl2 (0.730 g, 2.69 mmol) was added and the 
mixture stirred for an additional hour. Workup as for 9 gave crystals of (2-
ClHgC6H4)Ph2P=NC6H4F (0.927 g, 57%). Found: C 47.5, H 2.9, N 2.4; 
C24H18NFPClHg requires C 47.5, H 3.0, N 2.3%. NMR: 
1
H: δ (ppm) 6.69-6.75, 6.80-
6.85, 7.27-7.34, 7.40-7.70 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 9.0 (br), 3J(199Hg-P) = 320 
 16 
Hz. ESI-MS: m/z: 607 (100%, [M+H]
+
), 942 (35%, [2-
Hg({C6H4}Ph2P=NC6H4F)2+H]
+
). IR:  υ(P=N) = 1309 cm-1 (vs). 
 
Preparation of (2-ClHgC6H4)Ph2P=N
t
Bu
 
12 
As for 11 above, Ph3P=N
t
Bu 8 (1.199 g, 3.60 mmol) was added to a solution of PhBr 
(0.38 mL, 3.60 mmol) and 
n
BuLi (1.6 M, 2.25 mL, 3.60 mmol) in diethyl ether (20 
mL). Addition of HgCl2 (0.977 g, 3.60 mmol) followed by workup gave (2-
ClHgC6H4)Ph2P=N
t
Bu (0.909 g, 44%). Found: C 46.0, H 4.1, N 2.5; C22H23NPClHg 
requires C 46.4, H 4.1, N 2.5%. NMR: 
1
H: δ (ppm) 1.29 (s, CH3), 7.13-7.19, 7.31-
7.64, 7.74-7.81 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 2.2, 3J(199Hg-P) = 341 Hz. ESI-MS: 
m/z: 569 (100%, [M+H]
+
). IR:  υ(P=N) = 1223 cm-1 (vs). 
 
 
 
Alternative synthesis: 
Ph3P=N
t
Bu 8 (0.300 g, 0.90 mmol) and Hg(OAc)2 (0.288 g, 0.90 mmol) were 
refluxed under nitrogen in dry degassed THF (20 mL) for 16 h. The solution was 
allowed to cool, LiCl (0.076 g, 1.79 mmol) was added and stirred for an additional 4 
h. The solution was then filtered and evaporated to dryness. The filtrate was 
redissolved in dichloromethane (2 × 10 mL) and diethyl ether (20 mL) was added. 
Storage at -20 °C gave crystals of (2-ClHgC6H4)Ph2P=N
t
Bu (0.128 g, 25%), 
identified by 
1
H and 
31
P{
1
H} NMR spectroscopy. 
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Preparation of (2-Cl2AuC6H4)Ph2P=N-(R,S)-CHMePh 13   
The complex (2-BrHgC6H4)Ph2P=N-(R,S)-CHMePh 9 (0.100 g, 0.15 mmol), 
Me4N[AuCl4] (0.062 g, 0.15 mmol) and Me4NCl (0.016 g, 0.15 mmol) were added to 
degassed acetonitrile (15 mL) and stirred in a foil-covered flask for 48 h. The solvent 
was removed and the yellow solid extracted into dichloromethane (2 × 10 mL), 
filtered and diethyl ether was added to the filtrate. Storage at -20 °C gave yellow 
crystals of (2-Cl2AuC6H4)Ph2P=N-(R,S)-CHMePh) (0.062 g, 64%). Found: C 47.2, H 
3.5, N 2.1; C26H23NPCl2Au requires C 48.2, H 3.6, N 2.2%. NMR: 
1
H: δ (ppm) 1.62 
(d, CH3), 5.85 (m, CH), 6.92-7.01, 7.05-7.08, 7.18-7.23, 7.32-7.53, 7.58-7.67, 8.17-
8.21 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 59.0. ESI-MS: pyridine doped m/z: 654 (100%, 
[M-Cl+MeCN]
+
), 692 (85%, [M-Cl+py]
+
), 613 (53%, [M-Cl]
+
). IR:  υ(P=N) = 1138 
cm
-1
 (s). 
 
Preparation of (2-Cl2AuC6H4)Ph2P=N-(S)-CHMePh 14 
Analogous to 13, (2-BrHgC6H4)Ph2P=N-(S)-CHMePh 10 (1.000 g, 1.51 mmol), 
Me4N[AuCl4] (0.623 g, 1.51 mmol) and Me4NCl (0.166 g, 1.51 mmol) were reacted 
in acetonitrile (30 mL) for 48 h. Workup gave (2-Cl2AuC6H4)Ph2P=N-(S)-CHMePh) 
as pale yellow crystals (0.139 g, 14%). The product was identified by 
1
H and 
31
P{
1
H} 
NMR spectroscopy. 
 
Preparation of (2-Cl2AuC6H4)Ph2P=NC6H4F 15 
As for 13, (2-ClHgC6H4)Ph2P=NC6H4F 11 (0.174 g, 0.29 mmol), Me4N[AuCl4] 
(0.119 g, 0.29 mmol) and Me4NCl (0.032 g, 0.29 mmol) in acetonitrile (20 mL) for 
 18 
24 h. Work-up gave (2-Cl2AuC6H4)Ph2P=NC6H4F as bright yellow crystals (0.074 g, 
40%). Found: C 45.2, H 3.1, N 2.2; C24H18NFPCl2Au requires C 45.2, H 2.8, N 2.2%. 
NMR: 
1
H: δ (ppm) 6.73-6.80, 6.92-6.97, 7.10-7.17, 7.33-7.38, 7.49-7.62, 7.71-7.78, 
8.41-8.46 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 66.9. ESI-MS: m/z: 603 (100%, [M-Cl]+), 
1241 (80%, [2M-Cl]
+
); pyridine doped m/z: 682 (100%, [M-Cl+py]
+
). IR: υ(P=N) = 
1219 cm
-1
 (s). 
 
Preparation of (2-Cl2AuC6H4)Ph2P=N
t
Bu 16 
As for 13, (2-ClHgC6H4)Ph2P=N
t
Bu 12 (0.400 g, 0.70 mmol), Me4N[AuCl4] (0.291 
g, 0.70 mmol) and Me4NCl (0.077 g, 0.70 mmol) were reacted in acetonitrile (20 mL) 
for 24 h. Workup gave yellow crystals of (2-Cl2AuC6H4)Ph2P=N
t
Bu (0.312 g, 74%). 
Found: C 44.2, H 3.9, N 2.4; C22H23NPCl2Au requires C 44.0, H 3.9, N 2.3%. NMR: 
1
H:  δ (ppm) 1.34 (s, CH3), 7.31-7.40, 7.55-7.62, 7.67-7.72, 7.85-7.91, 8.04-8.07 (all 
m, Ar-H); 
31
P{
1
H}: δ (ppm) 46.1. ESI-MS: m/z: 565 (100%, [M-Cl]+), 673 (35%, 
[M+Me4N]
+
), 1165 (30%, [2M-Cl]
+
); pyridine doped m/z: 644 (100%, [M-Cl+py]
+
), 
565 (60%, [M-Cl]
+
). IR: υ(P=N) = 1183 cm-1 (m). 
 
Synthesis of 17 
The complex (2-Cl2AuC6H4)Ph2P=NPh 1 (0.100 g, 0.16 mmol) and catechol (0.018 g, 
0.16 mmol) were refluxed in methanol (20 mL). With stirring, Me3N (1 mL, excess) 
was added resulting in the yellow solution immediately turning dark orange. After 
refluxing for a further 20 min. the solution was allowed to cool, water (20 mL) was 
added and stirring continued overnight. The precipitate that had formed was filtered, 
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washed with water (2 × 10 mL) and diethyl ether (10 mL) and dried under vacuum to 
give 17 (0.085 g, 81%) as a rose-coloured solid. Found: C 54.8, H 3.6, N 2.2; 
C30H23NO2PAu requires C 54.8, H 3.5, N 2.1%. NMR: 
1
H: δ (ppm) 6.42-6.47, 6.73-
6.76, 7.01-7.15, 7.29-7.36, 7.49-7.57, 7.66-7.79, 8.19-8.22 (all m, Ar-H); 
31
P{
1
H}: δ 
(ppm) 60.9. ESI-MS: m/z: 658 (100%, [M+H]
+
), 1315 (60%, [2M+H]
+
);  NaCl doped 
m/z: 680 (100%, [M+Na]
+
), 1337 (34%, [2M+Na]
+
), 658 (28%, [M+H]
+
), 1315 (12%, 
[2M+H]
+
). IR: υ(P=N) = 1254 cm-1 (m). 
 
 
 
Synthesis of 18 
The complex (2-Cl2AuC6H4)Ph2P=N
t
Bu (0.100 g, 0.17 mmol) and catechol (0.019 g, 
0.17 mmol) were brought to reflux in methanol (15 mL). With stirring, Me3N (1 mL, 
excess) was added resulting in the yellow solution turning dark orange. After 
refluxing for a further 15 min. the now purple solution was allowed to cool, water (20 
mL) was added, and stirring continued overnight. The precipitate that had formed was 
filtered, washed with water (3 × 10 mL) and diethyl ether (20 mL) and dried under 
vacuum to give 18 (0.067 g, 62%) as a rose-coloured solid. A sample for 
microanalysis was recrystallised from dichloromethane/diethyl ether. Found: C 51.3, 
H 4.2, N 2.2; C28H27NO2PAu requires C 52.8, H 4.3, 2.2; C28H27AuNO2P · H2O 
requires C 51.3, H 4.5, N 2.1%. NMR: 
1
H: δ (ppm) 1.52 (s, CH3), 6.45-6.50, 6.53-
6.58, 6.67-6.79, 7.13-7.20, 7.34-7.39, 7.56-7.62, 7.66-7.71, 7.91-7.98, 8.11-8.14 (all 
m, Ar-H) 
31
P{
1
H}: δ (ppm) 55.7. ESI-MS: m/z:  638 (100%, [M+H]+), 1275 (30%, 
 20 
[2M+H]
+
); NaCl doped m/z: 660 (100%, [M+Na]
+
), 1297 (60%, [2M+Na]
+
), 638 
(40% [M+H]
+
). IR:  υ(P=N) = 1254 cm-1 (m). 
 
Synthesis of 19 
To a stirred methanolic solution (15 mL) of (2-Cl2AuC6H4)Ph2P=NPh 1 (0.100 g, 
0.16 mmol) and thiosalicylic acid (0.025 g, 0.16 mmol), Me3N (1 mL, excess) was 
added, resulting in the pale yellow solution immediately becoming darker. Stirring 
was continued in the dark for a further 90 min. before water (20 mL) was added. The 
fine yellow precipitate that had formed was filtered and washed with water (3 × 10 
mL) and diethyl ether (1 × 10 mL) and dried under vacuum to give 19 (0.099 g, 
88%). Found: C 53.1, H 3.4, N 2.0; C31H23NO2PSAu requires C 53.1, H 3.3, N 2.0%. 
NMR: 
1
H: δ (ppm) 6.88-6.92, 7.01-7.21, 7.28-7.35, 7.46-7.57, 7.64-7.75, 8.00-8.04, 
8.15-8.20 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 54.1. ESI-MS: m/z: 902 (100%, [2-
Au({C6H4}Ph2P=NPh)2]
+
), 703 (30%, [M+H]
+
), 1404 (25%, [2M+H]
+
); NaCl doped  
m/z:  901 (100%, [2-Au({C6H4}Ph2P=NPh)2]
+
), 1426 (85%, [2M+Na]
+
), 725 (40%, 
[M+Na]
+
), 703 (10%, [M+H]
+
), 1404 (7%, [2M+H]
+
). IR: υ(P=N) = 1316 cm-1 (m), 
υ(C=O) = 1626 cm-1 (vs). 
 
Synthesis of 20 
As for 19, (2-Cl2AuC6H4)Ph2P=N
t
Bu 16 (0.101 g, 0.17 mmol) and thiosalicylic acid 
(0.026 g, 0.17 mmol) were reacted in methanol (15 mL). Addition of Me3N (1 mL, 
excess) and water (20 mL) followed by workup gave 0.085 g (73%) of 20 as a yellow 
solid. Found: C 51.0, H 4.0, N 2.0; C29H27NO2PSAu requires C 51.1, H 4.0, N 2.1%. 
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NMR: 
1
H: δ 1.40 (s, CH3), 7.01-7.05, 7.15-7.25, 7.32-7.38, 7.43-7.47, 7.53-7.59, 
7.63-7.69, 7.86-7.99, 8.14-8.19 (all m, Ar-H); 
31
P{
1
H}: δ 43.2 ppm. ESI-MS: m/z: 
683 (100%, [M+H]
+
), 1212 (52%, unidentified), 1364 (30%, [2M+H]
+
); NaCl doped  
m/z: 705 (100%, [M+Na]
+
), 1386 (87%, [2M+Na]
+
). IR: υ(P=N) = 1310 cm-1 (m), 
υ(C=O) = 1626 cm-1 (vs). 
 
Synthesis of [(2-Cl(PPh3)AuC6H4)Ph2P=NPh]PF6 24 
The complex (2-Cl2AuC6H4)Ph2P=NPh 1 (0.104 g, 0.17 mmol), PPh3 (0.045 g, 0.17 
mmol) and NH4PF6 (0.111 g, 0.68 mmol) were stirred in dichloromethane (10 mL) 
for 4 h. The solution was filtered and the dark orange filtrate reduced in volume (~2 
mL). Diethyl ether was added until the solution went cloudy. Storage at -20 °C gave 
yellow crystals of [(2-Cl(PPh3)AuC6H4)Ph2P=NPh]PF6 (0.088 g, 52%). Found: C 
50.2, H 3.5, N 1.5; C42H34NF6P3ClAu requires C 50.9, H 3.5, N 1.4%. NMR: 
1
H: δ 
(ppm) 6.90-7.03, 7.09-7.14, 7.30-7.34, 7.51-7.57, 7.61-7.71, 7.78-7.87 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 60.6 (P=N), 41.0 (PPh3), 1:1 ratio. ESI-MS: m/z: 847 (100%, [(2-
Cl(PPh3)AuC6H4)Ph2P=NPh]
+
). IR: υ(P=N) = 1253 cm-1 (w). 
 
Synthesis of 27 
The complex (2-Cl2AuC6H4)Ph2P=NPh 1 (0.100 g, 0.16 mmol) and NaS2CNEt2 · 
3H2O (0.036 g, 0.16 mmol) were stirred in dichloromethane (10 mL) for 2.5 h. 
NH4PF6 (0.065 g, 0.40 mmol) was added and the solution stirred for an additional 18 
h. The insoluble material was removed by filtration and the yellow solution reduced 
in volume (~2 mL). Diethyl ether was added until the solution went cloudy. Storage 
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at -20 °C gave yellow microcrystals (0.099 g, 73%) of 27. Found: C 41.8, H 3.6, N 
3.2; C29H29N2F6P2S2Au requires C 41.3, H 3.5, N 3.3%. NMR: 
1
H: δ (ppm) 1.30 (t, 
CH3), 1.43 (t, CH3), 3.71 (q, CH2), 3.82 (q, CH2), 6.83-6.86, 7.06-7.12, 7.17-7.23, 
7.28-7.35, 7.39-7.43, 7.47-7.54, 7.57-7.80 (all m, Ar-H); 
31
P{
1
H}: δ (ppm) 65.9. ESI-
MS: m/z:  843 (100%, [M]
+
). IR: υ(P=N) = 1232 cm-1 (w). 
 
Crystal structure determinations of 14, 20 and 24 
Single crystals of X-ray quality were grown by vapour diffusion of either diethyl 
ether (14 and 24) or pentane (20) into a dichloromethane solution of the compound at 
room temperature. Both 14 and 24 crystallised as yellow blocks, 20 as orange plates. 
Data Collection 
Unit cell dimensions and intensity data (Table 5) were collected at the University of 
Canterbury on a Bruker Nonius Apex II CCD Diffractometer. Absorption was 
corrected for by semi-empirical methods (SADABS
44
). 
 
Solution and Refinement 
Structures were solved by either the direct methods (24) or Patterson (14 and 20) 
options of SHELXS-97.
45
 In all cases the gold atom was initially located, and all other 
atoms by a series of difference maps. Full-matrix least-squares refinement (SHELXL-
97
46
) was based upon F0
2
, with all non-hydrogen atoms refined anisotropically (with 
the exception of the cases mentioned below) and hydrogen atoms in calculated 
positions. 
 23 
 Complex 24 crystallised with the phosphorus of one PF6
-
 falling on an 
inversion centre. The other half anion was in a hole which contained both a PF6
-
 and a 
diethyl ether molecule (50:50 occupancy). Both the PF6
-
 and the diethyl ether showed 
considerable disorder and as a result were not refined anisotropically and the 
hydrogen atoms were excluded from the diethyl ether. Bond lengths in these species 
were constrained. 
 Complex 14 showed significant ripples around the gold after the final 
refinement. As a result, the anisotropic displacement parameters for C(12) and C(13) 
were unrealistic and thus were refined isotropically. 
 
 
Supplementary material 
Crystallographic data (excluding structure factors) for the structures described in this 
paper have been deposited with the Cambridge Crystallographic Data Centre, CCDC 
Nos. 699890 (14), 699891 (20) and 699892 (24). Copies of the data can be obtained 
free of charge on application to The Director, CCDC, 12 Union Road, Cambridge 
CB2 1EZ, UK (Fax: +44-1223-336033; e-mail deposit@ccdc.cam.ac.uk or www:  
http://www.ccdc.cam.ac.uk). 
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Table 1 Important structural parameters for (2-Cl2AuC6H4)Ph2P=N-(S)-CHMePh 14, 
with esds in parentheses 
 
Atoms Lengths (Å) Atoms Angles (°) 
Au(1)-Cl(1) 2.371(2) Cl(1)-Au(1)-Cl(2) 89.70(9) 
Au(1)-Cl(2) 2.297(3) N(1)-Au(1)-C(12) 85.1(4) 
Au(1)-N(1) 2.072(10) C(12)-Au(1)-Cl(2) 92.4(3) 
Au(1)-C(12) 2.045(8) N(1)-Au(1)-Cl(1) 93.0(3) 
P(1)-N(1) 1.615(10) N(1)-P(1)-C(11) 101.9(4) 
P(1)-C(11) 1.790(6) P(1)-N(1)-C(41) 131.4(8) 
N(1)-C(41) 1.473(12)   
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Table 2 Selected bond parameters for 20, with esds in parentheses 
 
Atoms Lengths (Å) Atoms Angles (°) 
N(1)–Au(1) 2.1196(13) N(1)–Au(1)–C(12) 85.90(6) 
C(12)–Au(1) 2.0194(16) O(2)–Au(1)–S(1) 91.46(4) 
O(2)–Au(1) 2.0676(13) C(3)–S(1)–Au(1) 103.08(6) 
S(1)–Au(1) 2.2760(4) O(1)–C(1)–O(2) 121.52(17) 
S(1)–C(3) 1.7618(17) C(1)–O(2)–Au(1) 130.92(11) 
O(1)–C(1) 1.226(2) O(1)–C(1)–C(2) 119.45(15) 
O(2)–C(1) 1.306(2)   
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Table 3 Selected bond parameters for [(2-Cl(PPh3)AuC6H4)Ph2P=NPh]PF6 · 0.5Et2O, 
with esds in parentheses 
 
Atoms Lengths (Å) Atoms Angles (°) 
Au(1)–Cl(1) 2.3463(11) N(1)–Au(1)–C(12) 84.0(2) 
Au(1)–P(2) 2.3030(12) C(12)–Au(1)–P(2) 92.88(17) 
Au(1)–C(12) 2.057(5) P(2)–Au(1)–Cl(1) 91.11(4) 
Au(1)–N(1) 2.079(5) Cl(1)–Au(1)–N(1) 92.26(13) 
P(1)–N(1) 1.620(6) Au(1)–N(1)–P(1) 108.3(3) 
N(1)–C(41) 1.419(7) P(1)–N(1)–C(41) 124.9(4) 
C(11)–C(12) 1.401(9) N(1)–P(1)–C(11) 100.6(3) 
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Table 4 Anti-tumour (P388 murine leukaemia) activities for selected gold(III) 
iminophosphoranes and related systems 
 
Complex                   IC50 
a
 
 ng mL
-1
 μM 
1 7546 10.7 
16 20021 33.4 
17 <487 <0.74 
18 655 1.03 
19 <487 <0.69 
20 658 0.97 
 
a
 Concentration of sample required to reduce the cell growth of the P388 murine leukaemia cell line by 
50%
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Table 5 Crystallographic details for 14, 20 and 24 
 
 
 14 20 24·0.5Et2O 
Formula C26H23NPCl2Au C29H27NO2PSAu C44H39NO0.5F6PClAu 
Molecular Weight 648.29 681.51 1029.09 
T/K 93 93 93 
Crystal system Triclinic Monoclinic Monoclinic 
Space group P1 P21/n C2/c 
a (Å) 9.0297(4) 9.0966(2) 50.109(2) 
b (Å) 9.2152(4) 17.4390(4) 9.8843(5) 
c (Å) 9.3699(4) 15.6240(4) 18.3601(8) 
α (°) 61.462(2) 90 90 
β (°) 63.334(2) 93.998(1) 111.043(2) 
γ (°) 61.134(2) 90 90 
V (Å
3
) 575.22(4) 2472.49(1) 8487.2(7) 
Z 1 4 8 
Dcalc (g cm
-3
) 1.871 1.831 1.611 
Tmax,min 0.5534, 0.0508 0.5267, 0.2164 0.530, 0.327 
Total reflections 
(Rint) 
7298 (0.0358) 44421 (0.0302) 64794 (0.0376) 
Number of unique 
reflections 
5778 10185 13986 
Number of observed 
reflections 
5273 8940 11379 
R [I>2σ(I)] 0.0319 0.0198 0.0536 
wR2 (all data) 0.077 0.0454 0.1385 
Goodness of Fit 1.062 1.016 1.142 
Flack x  parameter 0.005(7) - - 
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Scheme 1 Synthetic routes used for ortho-mercurated and cycloaurated 
iminophosphoranes 
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Scheme 2 Reaction of a) dampAuCl2 and b) papAuCl2 with PPh3 
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Captions for Figures 
 
Figure 1 ORTEP view of (2-Cl2AuC6H4)Ph2P=N-(S)-CHMePh 14, showing the atom 
numbering scheme. Thermal ellipsoids are shown at the 50% probability level. 
 
Figure 2 ORTEP diagram of 20, showing atom numbering scheme with ellipsoids 
shown at 50% probability. 
 
Figure 3 ORTEP diagram of 20, showing the fold angle of the thiosalicylate ligand 
and puckering of the iminophosphorane ring. For clarity, only the ipso carbons of the 
uncoordinated phenyl rings and the tertiary carbon of the Bu
t
 group are shown. 
Ellipsoids are shown at 50% probability. 
 
Figure 4 ORTEP diagram of [(2-Cl(PPh3)AuC6H4)Ph2P=NPh]
+
. Ellipsoids are shown 
at 30% probability. 
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